(Sharecast News) - Liquid biopsy company Angle has announced the resignations of its chief executive and finance director "following feedback and discussions with a significant shareholder".
The firm, which is focused on circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, said on Friday that...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE